Oct 22, 2026 06:40PM
Oct 19, 2026 04:05PM
Oct 19, 2026 04:05PM
Oct 12, 2026 06:52AM
Oct 12, 2026 02:24AM
Oct 9, 2026 09:00AM
Oct 2, 2026 04:30PM Mineralys Therapeutics Announces Presentation of New Lorundrostat Data at the American Society of Nephrology (ASN) Kidney Week 2026
Oct 1, 2026 04:05PM
Sep 23, 2026 04:06PM
Sep 23, 2026 04:05PM
Aug 11, 2026 04:05PM
Jun 14, 2026 02:01PM
Jun 14, 2026 10:00AM
Jun 8, 2026 07:00AM Mineralys Therapeutics to Present Late-Breaking Data on Lorundrostat at The Endocrine Society Annual Meeting (ENDO 2026)
Jun 3, 2026 06:01AM
Jun 3, 2026 06:00AM
Jun 1, 2026 01:46PM
May 30, 2026 11:15AM
May 30, 2026 11:15AM
May 30, 2026 11:15AM
May 18, 2026 04:05PM Mineralys Therapeutics to present lorundrostat data at European meeting
May 18, 2026 04:05PM
May 6, 2026 04:05PM
Mar 24, 2026 08:00AM
Mar 24, 2026 08:00AM
Mar 13, 2026 07:59AM
Mar 12, 2026 04:05PM
Mar 10, 2026 09:32AM Stifel Reiterates Buy Rating on Mineralys Therapeutics, Inc. (MLYS), Optimistic on lorundrostat
Mar 10, 2026 06:12AM
Mar 9, 2026 04:30PM
Mar 3, 2026 05:31PM
Jan 6, 2026 08:00AM
Dec 12, 2025 11:00AM
Dec 12, 2025 11:00AM
Nov 10, 2025 04:05PM Mineralys Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Nov 7, 2025 06:10PM
Oct 21, 2025 08:00AM
Oct 21, 2025 08:00AM
Sep 30, 2025 08:01AM
Sep 30, 2025 08:00AM
Sep 8, 2025 07:13AM
Sep 5, 2025 09:00AM Mineralys shows lorundrostat effective across diverse hypertension groups
Sep 5, 2025 09:00AM
Aug 12, 2025 04:05PM
Jul 14, 2025 08:20AM
Jun 30, 2025 11:19AM
Jun 30, 2025 11:17AM
Jun 18, 2025 06:44AM
Jun 17, 2025 07:00AM Mineralys Therapeutics (MLYS) Announces Positive Topline Results from Phase 2 Explore-CKD Trial
Jun 17, 2025 07:00AM

335,403 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All